Federico De Santis

29PUBLICATIONS
181CO-AUTHORS
Gene and molecular therapyHaematological tumoursMedical biotechnology diagnostics (incl. biosensors)HaematologyEpidemiological methods
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (29)

|Jun 26, 2026
SafeTy and effectiveness of Atogepant accoRding to the IHS outcome categories: A multicentric, prospective observational study in real life (the 24-week STAR study).

|Jun 19, 2026
Early versus Late starting of Direct Oral Anticoagulants after breakthrough ischemic stroke: A Target Trial Analysis from the ASPERA-R Study.

|Jun 05, 2026
Diagnostic tests and headache misdiagnoses in individuals with resistant and refractory migraine - data from the REFINE study.

|Apr 13, 2026
Competing Stroke Etiologies and Outcomes After Breakthrough Ischemic Stroke on Oral Anticoagulants in Patients With Atrial Fibrillation.

Matteo Foschi, Federico De Santis, Francesca Gabriele

|Mar 25, 2026
The chronopharmacology of atogepant in migraine prevention: A real-world evaluation of influence of timing of administration on effectiveness and tolerability.

Luigi Francesco Iannone, Gabriele Sebastianelli, Federico De Santis

|Mar 25, 2026
Timing of insertable cardiac monitor implantation after embolic stroke of undetermined source and its impact on atrial fibrillation detection: A target trial emulation analysis.

Lucio D'Anna, Fionn Maguidhir, Robert Simister

Pageof 5

Frequent Collaborators

23 joint publications

Raffaele Ornello

21 joint publications

Simona Sacco

19 joint publications

Matteo Foschi

7 joint publications

Lucio D'Anna